WAVE LIFE SCIENCES LTD. Lease Incentive, Payable, Current
WAVE LIFE SCIENCES LTD. (WVE) had Lease Incentive, Payable, Current of $1.16 million as of 2018-12-31, per its 10-K filed 2020-03-02.
Discontinued › Notes › Leases
us-gaap:LeaseIncentivePayableCurrent · last filed 2020-03-02
- 2018-12-31: Lease Incentive, Payable, Current $1.16M.
- 2018-09-30: Lease Incentive, Payable, Current $997.00K.
- 2018-06-30: Lease Incentive, Payable, Current $762.00K.
- 2018-03-31: Lease Incentive, Payable, Current $478.00K.
| Period end | Lease Incentive, Payable, Current |
|---|---|
| 2018-12-31 | $1.16M 10-K · filed 2020-03-02 |
| 2018-09-30 | $997.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $762.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $478.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $344.00K 10-K · filed 2019-03-01 |
| 2017-09-30 | $678.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $231.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $117.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $11.00K 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |